Feedback inhibitors in normal and tumor tissues

International Review of Cytology

Volumn 167, Issue , 1996, Pages 185-261

  Marshall, E ^a   Lord, B I ^b  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Feedback inhibition; Hemopoiesis; MIP 1

Indexed keywords

INTERFERON; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; TETRAPEPTIDE; TUMOR NECROSIS FACTOR;

CARCINOGENESIS; CELL PROLIFERATION; CELL SPECIFICITY; HEMATOPOIESIS; HUMAN; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; RAT; RECOMBINANT DNA TECHNOLOGY; REVIEW; STEM CELL; TUMOR; TUMOR PROMOTION; TUMOR SUPPRESSOR GENE;

EID: 0029797223     PISSN: 00747696     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0074-7696(08)61348-0     Document Type: Review

References (299)

1. Aggarwal, B. B., and Eessalu, T. E. (1987). Effects of phorbyl esters on down regulation and ' redistribution of cell surface receptors for tumour necrosis factor alpha. J, Biol. Chem. 262, 16450-16455.
2. Aggarwal, B. B., Eessalu, T. E., and Hass, P. E. (1985). Characterization of receptors for human tumour necrosis factor and their regulation by -y-interferon. Nature (London) 318, 665-667.
3. Andrews, R. G., Singer, J. W., and Bernstein, I. D. (1989). Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties. J. Exp. Med. 169, 1721-1731.
4. Arrick, B. A., and Nathan, C. F. (1984). Glutathione metabolism as a determinant of therapeutic efficacy. A review. Cancer Res. 44, 4224-4232.
5. | Assoian, R. K., Komoriya, A., Meyers, C. A., Miller, D. M., and Sporn, M.B. (1983). Transforming growth factor-β in human platelets. J. Biol. Chem. 258, 7155-7160.
6. Attisano, L., Wrana, J. L., Lopez-Castillas, F., and Massagué, J. (1994). TGF-β receptors and actions. Biochim. Biopliys. Acta 1222, 71-80.
7. Aulitzky, W. E., Tilg, H., Vogel, W., Aulitzky, W., Berger, M., Gas, H. G., Herold, M., and Huber, C. (1991). Acute haematologic effects of interferon alpha, interferon gamma, tumour necrosis factor and interleukin 2. Ann. Haematol. 62, 25-31.
8. II marrow negatively regulates DNA synthesis in erythropoietic progenitor cells BFU-E. Cell (Cambridge, Mass.) 26, 233-244.
9. Axelrad, A. A., Croizat, H. J., Eskinazi, D., Vaithilingham, D., and Van der Gaag, H. (1983). Genetic regulation of DNA synthesis in early erythropoietic progenitor cells:mechanisms and consequences for polycythaemia. Alfred Benzon Symp. 18, 234.
10. Axelrad, A. A., Croizat, H., Del Rizzo, D. F. Eskinazi, D., Pezzuti, G., Stewart, S., and Van der Gaag, H. (1989). Properties of a protein NRP that negatively regulates DNA synthesis of the early erythropoietic progenitor cells BFU-E. Colloq.-Inst. Natl. Sante Rech. Med. 162, 79-92.
11. Backx, B., Breeders, L., Bot, F. J., and Lowenberg, B. (1991). Positive and negative effects of tumour necrosis factor on colony growth from highly purified normal marrow progenitors. Leukaemia 5, 66-70.
12. Balkwill, F. R., Naylor, M. S., and Malik, S. (1990). Tumour necrosis factor as an anticancer agent. Eur. J. Cancer 26, 641-644.
13. Barr, P. J. (1991). Mammalian subtilisins: The long sought dibasic processing endoprotesses. Cell (Cambridge, Mass.) 66, 1-3.
14. Barton, D. E., Foellmer, B. E., Du, J., Tamm, J., Derynck, R., and Franke, U. (1988). Chromosomal locations of TGFs 2 and 3 in mouse and human. Oncogene Res. 3, 323-331.
15. Becker, A. J., McCulloch, E. A., Siminovitch, L., and Till, J. E. (1965). The effect of differing demands for blood cell production on DNA synthesis by haemopoietic colony forming cells of mice. Blood 26, 296-302.
16. Bhatia, R., McGlave, P. B., and Verfaillie, C. M. (1994). Interferon alpha treatment of normal bone marrow stroma results in enhanced adhesion of chronic myelogenous leukaemia haematopoietic progenitors via mechanisms involving MIP-1 alpha and TGFbeta. Exp. Hematol. (Copenhagen) 22, 797(abstr.).
17. Bichel, P. (1972). Specific growth regulation in three ascitic tumours. Eur. J. Cancer 8, 167-173.
18. Bischoff, S. C., Krieger, M., Brunner, T., Rot, A., Tscharner, V. V., Baggiolini, M., and Dahinden, C. A. (1993). RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptors. Eur. J. Immunol. 23, 761-767.
19. Blaydes, J. P., Schlumberger, M., Wynford-Thomas, D., and Wyllie, F. S. (1995). Interaction between p53 and TGF/31 in control of epithelial cell proliferation. Oncogene 10, 307-317.
20. Blum, S., Forsdyke, R. E., and Forsdyke, D. R. (1990). Three human homologs of a murine gene encoding an inhibitor of stem cell proliferation. DNA Cell Biol. 9, 589-602.
21. Bogden, A. E., Carde, P., Deschamps de Paillete, E., Moreau, J. P., Tubiano, M., and Frindel, E. (1991). Amelioration of chemotherapy-induced toxicity by co-treatment with AcSDKP, a tetrapeptide inhibitor of haematopoietic stem cell proliferation. Ann. N. Y. Acad. Aci. 628, 126-139.
22. Bonnet, D., Cesaire, R., Lemoine, F., Aoudjhane, M., Najman, A., Guigon, M. (1992). Reversible inhibitory effects and absence of toxicity of the tetrapeptide Acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in human long-term bone marrow culture. Exp. Hematol. (Copenhagen) 20, 1165-1169.
23. + subpopulations in response to growth factors. Blood 82, 3307-3314.
24. + progenitors. Exp. Hematol. (Copenhagen) 23, 551-556.
25. Breathnach, S. M. (1991). Origin, cell lineage, ontogeny, tissue distribution and kinetics of Langerhans cells. In "Epidermal Langerhans Cells" (G. Schuler, ed.), pp. 23-47. CRC Press, Boca Raton, FL.
26. Brockhaus M., Schoenfeld, H. J., Schlaeger, E. J., Hunziker, W., Lesslauer, W., and Loetscher, H. (1990). Indentification of two types of tumour necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl Acad. Sci. U.S.A. 87, 3127-3131.
27. Brown, K. D., Zurawski, S. M., Mosmann, T. D., and Zurawski, G. (1989). A family of inducible proteins secreted by leukocyte are members of a new superfamily that includes leukocytes and fibroblast-derived inflammatory agents, growth factors and indicators of various activation processes. J. Immunol. 142, 679-687.
28. Broxmeyer, H. E., Smithyman, A., Eger, R. R., Meyers, P. A., and deSousa, M. (1978). Identification of lactoferrin as the granulocyte-derived inhibitor of colony stimulating activity (CSA)-production. J. Exp. Med. 48, 1052-1067.
29. Broxmeyer, H. E., deSousa, M., Smithyman, A., Ralph, P., Hamilton, J., Kurland, J. I., and Bognacki, J. (1980). Specificity and modulation of the action of lactoferrin, a negative feedback regulator of myelopoiesis. Blood 55, 324-333.
30. Broxmeyer, H. E., Bognacki, J., Dorner, M. H., and deSousa, M. (1981). The identification of leukaemia-associated inhibitory activity (LIA) as acidic isoferritins: A regulatory role for acidic isoferritins in the protection of granulocytes and macrophages. J. Exp. Med. 153, 1426-1444.
31. Broxmeyer, H. E., Lu, L., Platzer, E., Feit, C, Juliano, L. and Rubin, B. Y. (1983). Comparative analysis of the influence of human gamma, alpha and beta interferons on human multipoten-tial (CFU-GEMM) erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. J. Immunol 131, 1300-1305.
32. Broxmeyer, H. E., Bognocki, J., Ralph, P., Dorner, M. H., Lu, L., and Castro-Malaspina, H. (1984a). Monocyte-macrophage derived acidic isoferritins, normal feedback regulators of granulocyte-macrophage and progenitor cells. Blood 60, 595-607.
33. Broxmeyer, H. E., Cooper, S., Lu, L., Juliano, J., Piacibello, W., Meyer, P. A., and Cavanna, F. (1984b). Functional activities of acidic isoferritins and lactoferrin in vitro and in vivo. Blood Cells 10, 397-426.
34. Broxmeyer, H. E., and Platzer, E. (1984c). Lactoferrin acts on I-A and I-E/c antigen-positive subpopulations of mouse peritoneal macrophages in the absence of T-lymphocytes and other cell types to inhibit production of granulocyte-macrophage colony stimulatory factors in vitro. J. Immunol. 133, 306-314.
35. Broxmeyer, H. E., Cooper, S., Rubin, B. Y., and Taylor, M. W. (1985). The synergestic influence of human interferon-y and interferon-a on suppression of hematopoietic progenitor cells is additive with the enhanced sensitivity of these cells to inhibition by interferons at low oxygen tension in vitro. J. Immunol. 135, 2502-2506.
36. Broxmeyer, H. E., Lu, L., Bicknell, D. C, Williams, D. E., Cooper, S., Levi, S., Salfeld, J., and Arosio, P. (1986a). The influence of purified recombinant human heavy-subunit and light-subunit ferritins of colony formation in vitro by granulocyte-macrophage and erythroid progenitor cells. Blood 68, 1257-1263.
37. Broxmeyer, H. E., Williams, D. E., Lu, L., Cooper, S., Anderson, S. L., Beyer, G. S., Huffman, R., and Rubin, B. Y. (1986b). The suppressive influences of human tumour necrosis factor on bone marrow haematopoietic progenitor cells from normal donors and patients with leukaemia: Synergism of tumour necrosis factor and interferon-y. J. Immunol. 136, 4487-4495.
38. Broxmeyer, H. E., Sherry, B., Lu, L., Cooper, S., Carob, C, Wolpe, S. D., and Cerami, A. (1989). Myelopoietic enhancing effects of murine macrophage inflammatory proteins 1 and 2 on colony formation in vitro by murine and human bone marrow granulocyte macrophage progenitor cells. J. Exp. Med. 170, 1583-1594.
39. Broxmeyer, H. E., Sherry, B., Lu, L., Cooper, S., and Oh, K., Tekamp-Olson, P., Byoung, S. K., and Cerami, A. (1990). Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells. Blood 76, 1110-1116.
40. Broxmeyer, H. E., Sherry, B., and Cooper, S. (1991). Macrophage inflammatory protein (MIP) 1β abrogates the capacity of MIPlo; to suppress myeloid progenitor cell growth. J. Immunol. 147, 2978-2983.
41. Buchkovitch, K., Duffy, L. A., and Harlow, E. (1989). The retinoblastoma protein is phosphorylated during specific phase of the cell cycle. Cell (Cambridge, Mass.) 58, 1097-1105.
42. Bullough, W. S., and Lawrence, E. B. (1960). The control of epidermal mitotic activity in the mouse. Proc. R. Soc. London, Ser. B 151, 517-536.
43. Cannistra, S. A., Groshek, P., and Griffin, J. D. (1988). Monocytes enhance gamma-interferon-induced inhibition of myeloid progenitor cell growth through secretion of tumour necrosis factor. Exp. Hematol. (Copenhagen) 16, 865-870.
44. Carde, P. et al. (1992). Seraspenide(acetyl SDKP): Etude en phase MI d'un inhibiteur de l'hematopoiese la protégeant de la toxicité de monochimiothérapies aracytine et ifosfamide. C. R. Acad. Sci. 315, 545-550.
45. Carlino, J., Higley, H., Avis, P., Chu, S., Ogawa, Y., and Ellingsworth, L. (1990). Haematologic and haematopoietic changes induced by systemic administration of TGFβ1. Ann. N.Y. Acad. Sci. 393, 326-333.
46. Carmichael, J., Friedeman, N., and Tochner, Z. (1986). Inhibition of the protective effect of cyclophosphamide by pretreatment with buthionine sulphoxime. Int. J. Radiát. Oncol. Biol. Phys. 12, 1191-1193.
47. Carswell, E. A., Old, L. J., Kassel, R. J., Green, S., Fiore, N., and Williamson, B. (1975). An endotoxin-induced serum factor which causes necrosis of tumours. Proc. Natl. Acad. Sci. U.S.A. 72, 3666-3670.
48. Cashman, J. D., Eaves, A. C., and Eaves, C. J. (1985). Regulated proliferation of primitive haematopoietic progenitor cells in long-term human marrow cultures. Blood 66, 1002-1005.
49. Cashman, J. D., Eaves, A. C, Raines, E. W., Ross, R., and Eaves, C. J. (1990). Mechanisms that regulate the cell cycle status of very primitive haematopoietic cells in long term bone marrow cultures. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF/3. Blood 75, 96-101.
50. Cashman, J. D., Eaves, A. C, and Eaves, C. J. (1994). The tetrapeptide AcSDKP specifically blocks the cycling of primitive normal but not leukaemic progenitors in long term cultures: Evidence for an indirect mechanism. Blood 84, 1534-1542.
51. + haematopoietic progenitor cells. Blood 75, 2292-2298.
52. Cazzola, M., Bergamaschi, G., Rezza, L., and Arosio, P. (1990). Manipulations of cellular iron metabolim for modulating normal and malignant cell proliferation: Achievement and prospects. Blood 75, 1903-1919.
53. Chasseaud, L. F. (1979). The role of glutathione and glutathione-s-transferases in the metabolism of chemical carcinogens and other electrophil agents. Adv. Cancer Res. 29, 175-273.
54. Cheifetz, S., Like, B., and Massagué, J. (1986). Cellular distribution of type I and type II receptors for transforming growth factor beta. J. Biol. Chem. 261, 9972-9978.
55. Chen, P. L., Scully, P., Shew, J. Y., Wang, J. Y., and Lee, W. H. (1989). Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell (Cambridge, Mass.) 58, 1193-1198.
56. Chen, R. H., Ebner, R., and Derynck, R. (1993). Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities. Science 260, 1335-1338.
57. Chuncharunee, S., Carter, C. D., Studtmann, K. E., Caro, J., Coffey, R. J., and Dessypris, E. N. (1993). Chronic administration of transforming growth factor-beta suppresses erythropoietin-dependent erythropoiesis and induces tumour necrosis factor in vivo. Br. J. Haematol. 84, 374-380.
58. Clements, J. M., Craig, S., Gearing, A. J. H., Hunter, M. G., Heyworth, C. M., Dexter, T. M., and Lord, B. I. (1992). Biological and structural properties of MIP-la expressed in yeast. Cytokine 4, 76-82.
59. Coffey, R. J., Bascom, C. C., Sipes, N. J., Graves-Deal, R., Weissman, B. E., and Moses, H. L. (1988). Growth modulation of mouse keratinocytes by transforming growth factor beta. Mol. Cell. Biol. 8, 3088-3093.
60. Coffey, R. J., Kost, L. J., Lyons, R. M., Moses, H. L., and La Russo, N. F. (1987). Hepatic processing of transforming growth factor beta in the rat. Uptake, metabolism and biliary excretion. J. Clin. Invest. 80, 750-757.
61. Cooper, S., Martel, C., Broxmeyer, H. E., Tekamp-Olon, P., Byoung, S. K., and Cerami, A. (1994). Myelosuppressive effects in vivo with very low dosages of monomeric recombinant murine macrophate inflammatory protein-la Exp. Hematol. (Copenhagen) 22, 186-193.
62. Cork, M. J., Riches, A. C, and Wright, E. G. (1986). A stimulator of murine haematopoietic stem cell proliferation produced by human fetal liver cells. Br. J. Haematol. 63, 775-783.
63. Dainiak, N., Guigon, N., Broxmeyer, H. E., Lemoine, F., and Najman, A. (1994). Meeting on negative regulation of heamatopoietic cell growth and differentiation. Exp. Hematol. (Copenhagen) 22, 399-405.
64. Davatelis, G., Wolpe, S. D., Sherry, B., Dayer, J. M., Chicheportiche, R., and Cerami, A. (1989). Macrophage inflammatory protein-1: A prostaglandin-independent endogenous pyrogen. Science 243, 1066-1068.
65. De Klein, A., Geurtvan Kessel, A., Grosveld, G., Bartram, C. R., Hagemeijer, A., Bootsma, D., Spurr, N. K., Heirsterkamp, N., Groffen, J., and Stephenson, J. R. (1982). A cellular oncogene is translocated to the Philadelphia chromosone in chronic myelocytic leukaemia. Nature (London) 300, 765-767.
66. Del Rizzo, D. F., Eskinazi, D., and Axelrad, A. A. (1990). Interleukin 3 opposes the action of negative regulatory protein (NRP) and synthesis of the erythroid stem cell BFU-E. Exp. Hematol. (Copenhagen) 18, 138-142.
67. Derynck, R., Jarrett, J. A., Chen, E. Y., Eaton, D. H., and Bell, J. R. (1985). Human transforming growth factor-β complimentary DNA sequence and expression in normal and transformed cells. Nature (London) 316, 701-705.
68. De Vos, S., Brach, M. A., Asano, Y., Ludweig, W. D., Bettelheim, P., Gruss, H.-J., and Hermann, F. (1993). Transforming growth factor beta 1 interferes with the proliferatinginducing activity of stem cell factor in myelogenous leukaemia blasts through functional down-regulation of the c-kit proto-oncogene product. Cancer Res. S3, 3638-3642.
69. Dewys, W. D., Goldin, A., and Mantel, N. (1970). Haematopoietic recovery after large doses of cyclophorphamide. Correlation of proliferative state with sensitivity. Cancer. Res. 30, 1692-1697.
70. Dexter, T. M., Allen, T. D., Lajtha, L. G., Krizsa, F., Testa, N. G., and Moore, M. A. S. (1978). In vitro analysis of self-renewal and commitment of haemopoietic stem cells. Cold Spring Harbor Conf. Cell Proliferation 5, 63.
71. Dezza, L., Cazzola, M., Bergamaschi, G., Stell, C. C., Pedrazzoli, P., Aglietta, M., and Ascari, E. (1987). Inhibitory activity of recombinant human H-subunit ferritin on the in vitro growth of human granulocyte-macrophage progenitor cells. Colloq.-Inst. Natl. Sante Rech. Med. 162, 59-62.
72. Dolittle, R. F., Hunkapiller, M. W., Hood, L. E., Devare, S. G., Robbins, K. C., Aaronson, S. A., and Antoniades, H. N. (1983). Simian sarcoma virus one gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science 221, 275-277.
73. Donehower, L. A., and Bradley, A. (1993). The tumour suppressor P53. Biochim. Biophys. Acta 1155, 181-205.
74. Downward, J., Yarden, Y., Mayes, E., Scrace, G., Totty, N., Stockwell, P., Ulrich, A., Schles-singer, J., and Waterfield, M. D. (1984). Close similarity of epidermal growth factor receptor and v-erbB oncogene protein sequences. Nature (London) 307, 521-527.
75. Dubois, C. M., Ruscetti, F. S., Pabaszynski, E. W., Falk, L. A., Oppenheimer, J. J., and Keller, J. R. (1990). Transforming growth factor beta is a potent inhibitor of interleukin-1 (IL-1) receptor expression: Proposed mechanism of inhibition of IL-1 action. J. Exp. Med. 172, 737-744.
76. Dunlop, D. J, Wright, E. G., Lonmore, S., Graham, G. J., Holyoake, T., Kerr, D. T., Wolpe, S. D., and Pragnell, I. B. (1992). Demonstration of stem cell inhibition and myeloproliferative effects of SCI/rhMIPla in vivo. Blood 9, 2221-2225.
77. Eaves, A. C, Cashman, J. E., Gaboury, L. A., Kalousek, D. K., and Eaves, C. J. (1986). Unregulated proliferation of primitive chronic myeloid leukaemia progenitors in the presence of normal marrow adherent cells. Proc. Natl. Acad. Sci.. U.S.A. 83, 5306-5310.
78. Eaves, C. J., Cashman, J. D., Kay, R. J., Dougherty, G. J., Otsuka, T., Gaboury, L. A., Hogge, D. E., Landsdorp, P. M., and Eaves, A. C. (1991). Mechanism that regulate the cell cycle status of very primitive haematopoietic cells in long term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood 78, 110-117.
79. Eaves, C. J., Cashman, J. D., Wolpe, J. D., and Eaves, A. C. (1993a). Unresponsiveness of primitive chronic myeloid leukaemia cells to macrophage inflammatory protein lor, an inhibitor of primitive normal haematopoietic cells. Proc. Natl. Acad. Sci.. U.S.A. 90, 12015-12019.
80. Eaves, C. J., Cashman, J. D., Zoumbos, N. C, Barnett, M. J., and Eaves, A. C. (1993b). Biological strategies for the selective manipulation of normal and leukaemic stem cells. Stem Cells 11 Suppl. 3, 109-121.
81. Ellingsworth, L. R., Brennan, J. E., Fok, K., Rosen, D. M., Bentz, H., Fiez, K. A., and Seyedin, S. M. (1986). Antibodies to the N-terminal portion of cartilage-inducing factor A and transforming growth factor-α. J. Biol. Chem. 261, 12362-12367.
82. Fafeur, V., O'Hara, B., and Bohlen, P. (1993). A glycosylation-deficient endothelial cell mutant with modified responses to transforming growth factor beta and other inhibitory cytokines: Evidence for multiple growth inhibitory signal transduction pathways. Mol. Biol. Cell 4, 135-144.
83. Falk, L. A., De-Benedette, F., Lohrey, N., Birchenall-Roberts, M. C., Faltynek, C. R., and Ruscetti, F. (1991). Induction of transforming growth factor beta l (TGF-β1) receptor expression and TGF-β1 protein production in retinoic acid-treated HL60 cells: Possible TGF-β1-mediated autocrine inhibition. Blood 77, 1248-1255.
84. Ferrajoli, A., Talpaz, M., Zipf, T. F., Hirsch-Ginsberg, C, Estey, E., Wolpe, S. D., and Estrov, Z. (1994). Inhibition of acute myelogenous leukaemia progenitor proliferation by macrophage inflammatory protein-la. Leukaemia 8, 798-805.
85. Fetsch, J., and Maurer, H. R. (1987). A specific, low molecular mass granulopoiesis inhibitor, isolated from calf spleen. Colloq.-Inst. Natl. Sante Rech. Med. 162, 55-58.
86. Forcher, B. K., and Houck, J. C., eds. (1973). Chalones; concepts and current researches. Natl. Cancer hut. Monogr. 38, 233.
87. Forsburg, S. L., and Nurse, P. (1991). Cell cycle regulation in the yeasts Saccaromyces cerevisiae and Schizosaccharomyces pombe. Anna. Rev. Cell Biol. 7, 227-256.
88. Friend, S. H., Horowitz, J. M. Gerber, M. R., Wang, X. F., Bogenman, E., Li, F. P., and Weinberg, R. A. (1987). Deletions of a DNA-sequence in retinoblastomas and mesenchymal tumours: Organization of the sequence and its encoded protein. Proc. Natl. Acad. Sci. U.S.A. 84, 9059-9063.
89. Frindel, E., and Guigon, M. (1977). Inhibition of CPU entry into cycle by a bone marrow extract. Exp. (Hematol. Copenhagen) 5, 74-76.
90. Frindle, E., and Monpezat, J. P. (1989). The physiological role of the endogenous colony forming units-spleen (CFu-S) inhibitor Acertyl-N-Ser-Asp-Lys-Pro (AcSDKP). Leukaemia 3, 753-754.
91. Frindel, E., Masse, A., Pradelles, P., Volkov, L., and Rigand, M. (1992). The correlation of endogenous AcSDKP plasma levels in mice and the kinetics of CFU-S entry into cycle after AraC treatment. Fundamental and clinical aspects. Leukaemia 6, 559-601.
92. Frolik, C. A., Dart, L. L., Meyers, C. A., Smith, D. M., and Sporn, M. B. (1983). Purification and initial characterisation of a type β transforming growth factor from human placenta. Proc. Natl Acad. Sci. U.S.A. 80, 3676-3680.
93. Frostad, S., Kalland, T., Aakvaag, A., and Laerum, O. D. (1993). Haemoregulatory peptide (HP5b) dimer effects on normal and malignant cells in culture. Stem Cells 11, 303-311.
94. Gao, J.-L., Kuhns, D. B., Tiffany, H. L., McDermott, D., Li, X., Francke, U., and Murphy, P. M. (1993). Structure and functional expression of the human macrophage inflammatory protein lo/RANTES Receptor. J. Exp. Med. 177, 1421-1427.
95. Geng, Y., and Weinberg, R. A. (1993). Transforming growth factor beta effects on expression of GI cyclins and cyclin-dependent protein kinases. Proc. Natl. Acad. Sci. U.S.A. 90, 10315-10319.
96. Gentile, P., and Broxmeyer, H. E. (1991). Interleukin-6 ablates the accessory cell-mediated suppressive effects of lactoferrin on human haematopoietic progenitor cell proliferation in vitro. In negative regulators of haematopoiesis. Ann. N. Y. Acad. Sci. 628, 74-83.
97. Gidali, J. G., and Lajtha, L. G. (1972). Regulation of haemopoietic stem cell turnover in partially irradiated mice. Cell Tissue Kinet. 5, 147-157.
98. Gilraith, P. R. (1986). Effects of lactoferrin on human granulopoiesis in vitro. Clin. Invest. Med. 9, 1-5.
99. Goey, H., Keller, J. R., Back, T., Longo, D. L., Ruscetti, F. W., and Wiltrout, R. H. (1989). Inhibition of early murine haematopoietic progenitor cell proliferation after in vivo locoregional administration of transforming growth factor-Bl. J. Immimol. 143, 877-880.
100. Goodrich, D. W., Ping-Wang, N., Quian, Y. W., Lee, E. Y.-H. P., and Lee, W. (1991). The retinoblastoma gene product regulates progression through the GI phase if the cell cycle. Cell (Cambridge, Mass.) 67, 293-302.
101. Graham, G. J., and Pragnell, I. B. (1992). SCI/MIPla: A potent stem cell inhibitor with potential roles in development. Dev. Biol. 151, 377-381.
102. Graham, G. J., Wright, E. G., Hewick, R., Wolpe, S. D., Wilkie, N. M., Donaldson, D., Lorimore, S., and Pragnell, I. B. (1990). Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature (London) 344, 442-444.
103. Graham, G. J., Zhou, L., Weatherbee, J. A., Tsang, M. L.-S., Napolitano, M., Leonard, W. J., and Pragnell, L. B. (1993). Characterization of a receptor of MIPla and related proteins on human and murine cell. Cell Growth Differ. 4, 137-146.
104. Graham, G. J., Mackenzie, J., Lowe, S., Lik-Shing Tsang, M., Weatherbee, J. A., Issacson, A., Medicherla, J., Fang, F., Wilkinson, P. C, and Pragnell, I. B. (1994). Aggregation of the chemokine MIPla is a dynamic and reversible phenomenon. J. Biol. Chem. 269, 4974-4978.
105. Greenberg, S. M., Chandrasekhar, C, Golan, D. E., and Hardin, R. J. (1990). Transforming growth factor beta inhibits endomitosis in the Dami human megakaryocyte cell line. Blood 76, 533-537.
106. Grillon, C, Prieger, K., Bakala, J., School, D., Morgat, J. L., Hannpaspel, I., Voelter, W., and Lenfant, M. (1990). Involvement of thymosine beta 4 and endopeptide AspN in biosynthesis of the tetrapeptide Ac-Ser-Asp-lys-Pro, a regulator of the haematopoietic system. FEBS Lett. 274, 30-34.
107. Grillon, C., Lenfant, M., and Wdzieczak-Bakala, J. (1993). Optimization of cell culture conditions for the evaluation of the biological activities of the tetrapeptide N-acetyl-Ser-Asp-Lys-Pro, a natural hemoregulatory factor. Growth Factors 9, 133-138.
108. Grillon, C, Bonnet, D., Mary, J.-Y., Lenfant, M., Najman, A., and Guigon, M. (1994). The tetrapeptide AcSerAspLysPro (Seraspenide), a haematopoietic inhibitor, may reduce the in vitro toxicity of 3'Azido-3' deoxythymidine to human haematopoietic progenitors. Stem Cells 11, 455-464.
109. Guigon, M., Enouf, J., and Frindel, E. (1980). Effects of CFU-S inhibitors on murine bone marrow during Ara C treatment. I. Effects on stem cells. Leak. Res. 4, 385-391.
110. Guigon, M., Bonnet, D., Lemoine, F., Kobari, L., Parmentier, C., Mary, J. Y., and Najman, A. (1990). Inhibition of human bone marrow progenitors by the synthetic tetrapeptide AcSDKP. Exp. Hemalol. (Copenhagen) 18, 1112-1115.
111. Guigon, M., Bonnet, D., Cesaire, R., Lemoine, F. M., and Najman, A. (1991). Effects of small peptide inhibitors of murine stem cells on normal and malignant cells. Ann. N.Y. Acad. Sci. 628, 105-114.
112. Hakovirta, H., Vierula, M., Wolpe, S. D., and Parvinen, M. (1994). MIP1-α is a regulator of mitotic and mieotic DNA synthesis during spermatogenesis. Mol. Cell. Endocrinol. 99, 119-124.
113. Hampson, J., Lord, B. I., Redmond, S., and Slocombe, P. (1991). Inhibition of haematopoietic colony-forming cells. Normal bone marrow extract versus transforming growth factor betal. Ann. N. Y. Acad. Sci. 628, 44-51.
114. Hieber, U., and Heim, M. (1994). Tumour necrosis factor of the treatment of malignancies. Oncology 51, 142-153.
115. Hodgson, G. S., and Bradley, T. R. (1979). Properties of haemopoietic stem cells surviving 5-Fluorouracil treatment; evidence for a pre-CFU-S cell. Nature (London) 281, 381-382.
116. Hodgson, G. S., Bradley, T. R., Martin, R. F., Sumner, M., and Fry, P. (1975). Recovery of proliferating haemopoietic progenitor cells after killing by hydroxyurea. Cell Tissue Kinet. 8, 51-60.
117. Hohmann, H. P., Remy, R., Brockhaus, M., van Loon, A. P. G. M. (1989). Two different cell types have different major receptors for human tumour necrosis factor (TNFa). J. Biol. Chem. 264, 14927-14934.
118. Holyoake, T. L., Freshney, M. G., Spoul, A. M., Richmond, L. J., Alcorn, M. J., Steward, W. P., Fitsimmons, E., Dunlop, D. J., Franklin, I. M., and Pragnell, I. B. (1993). Contrasting effects of rhMip-a and TGF-/31 on chronic myeloid leukaemia progenitors in vitro. Stem Cells 11, Suppl. 3, 122-128.
119. Hornung, R. L., and Longo, D. L. (1992). Haematopoeitic stem cell depletion by restorative growth factor regimens during repeated high dose cyclophosphamide therapy. Blood 80, 77-83.
120. Howard, A., and Pèle, S. R., (1953). Synthesis of deoxyribonucleic acid in normal and irradiated cells and its relation to chromosome breakage. Heredity 6, (Suppl.) 261-273.
121. Ignotz, R. A., and Massagué, J. (1987a). Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor β. J. Biol. Chem. 262, 6443-6446.
122. Ignotz, R. A., and Massagué, J. (1987b). Cell adhesion receptors as targets for transforming growth factor beta action. Cell (Cambridge, Mass.) 51, 189-197.
123. Ignotz, R. A., Heino, J., and Massagué, J. (1989). Regulation of cell adhesion receptors by transforming growth factor beta. Regulation of vitronectin receptor and LFA-1. J. Biol. Chem. 264, 389-392.
124. Israels, L. G., Jesson, M. L, Israels, S., Greenberg, A. H., Begleiter, A., Mowat, M. R. A., and Johnston, J. B. (1990). Activity of TGF-α in chronic lymphocytic leukaemia (CLL) in vitro. Blood 76, Suppl. 1, 2839 (abstr.).
125. Iverson, O. H. (1968). Changes in cell metabolism in experimental skin carcinogenesis. Acta Pathol. Microbiol. Scand. 50, 17-24.
126. Jagel, M. A., and Hugli, T. E. (1992). Neutrophil chemotactic factors promote leucocytosis. J. Immunol. 148, 1119-1128.
127. Jalkowlew, S. B., Dillard, P. J., Sporn, M. B., and Roberts, A. B. (1988). Complementary deoxyribonucleic acid cloning of a messenger ribonucleic acid encoding transforming growth factor beta 4 from chicken embryo chondrocytes. Mol. Endocrinology 2, 1186-1195.
128. Jensen, P. J., Elgjo, K., Laerum, O. D., and Bolund, L. (1990). Synthetic epidermal pentapeptide and related growth regulatory peptides inhibit proliferation and enhance differentation in primary and regenerating cultures of human epidermal keratinocytes. J. Cell Sci. 97, 51-58.
129. Keller, J. R., Mantel, C, Sing, G. R., Ellingsworth, L. R., Quesenberry, P., Sing, G. K., and Ruscetti, F. W. (1988). Transforming growth factor β selectively regulates early haematopoietic progenitors and inhibits the growth of IL-3 dependent myeloid leukaemic cell lines. J. Exp. Med. 168, 737-750.
130. Keller, J. R., McNiece, I. K., Sill, K. J., Ellingsworth, L. R., Quesenberry, P., Sing, G. K., and Ruscetti, F. W. (1990). Transforming growth factor beta directly regulates primitive murine haemopoietic cell proliferation. Blood 3, 596-602.
131. Keller, J. R., Bartelmez, S. H., Sitnicka, R., Ruscetti, F. W., Oritz, M., Gooya, J. M., and Jacobsen, S. E. N. (1994). Distinct and overlapping direct effects of macrophage inflammatory protein-la and transforming growth factor β on haematopoietic progenitor/stem cell growth. Blood 84, 2175-2181.
132. Keski-Oja, J., Leof, E. B., Lyons, R. M., Coffey, R. J., Jr., and Moses, H. L. (1987). Transforming growth factors and control of neoplastic cell growth. J. Cell Biol. 33, 95-107.
133. Kirn, S. H., and Kim, J. H. (1972). Lethal effect of adriamycin on the division cycle of Hela cells. Cancer Res. 32, 323-325.
134. King, A. G., Talmadge, J. E., Badger, A. M., and Pelus, L. M. (1992). Regulation of colony-stimulating activity production from bone marrow stromal cells by the hematoregulatory peptide HP5b. Exp. Hematol. (Copenhagen) 20, 223-228.
135. Kivilaasko, E., and Rytomaa, T. (1971). Erythrocyte chalone, a tissue specific inhibitor of cell proliferation in the erythron. Cell Tissue Kinet. 4, 1-9.
136. Koeffler, H., Gasson, J., Ranyard, J., Souza, L., Shepard, M., and Munker, R. (1987). Recombinant human TNFa stimulates production of granulocyte colony-stimulatory factor. Blood 70, 55-59.
137. 2-interferon by tumour necrosis factor. A homeostasis mechanism in the control of cell proliferation. Cell (Cambridge, Mass.) 45, 659-666.
138. Kondaiah, P., Sands, M. J., Smith, J. M., Fields, A., and Roberts, A. B. (1990). Identification of a novel transforming growth factor-β (TGF-β5) mRNA in Xenopits laevis. J. Biol. Chem. 265, 1089-1093.
139. Konopka, J. B., Watanabe, S. M., and Witte, O. N. (1984). An alteration of the human c-abl protein in K562 leukaemia cells unmasks associated tyrosine kinase activity. Cell (Cambridge, Mass.) 37, 1035-1042.
140. Korfei, A., Marschall, Z. V., Koenigsman, M., Oberberg, D., Reufi, B., Thiel, E., and Berdel, W. E. (1994). Macrophage inflammatory protein (MIP)-1α/stem cell inhibitor (SCI) does not affect clonal growth of human solid tumour cell lines in vitro. Int. J. Oncol. 4, 353-357.
141. Kreja, L., Haga, P., Miiller-Berat, N., Laerum, O. D., Sletvold, O., and Paukovits, W. R. (1986). Effects of a haemoregulatory peptide (HP5b) on erythroid and meylopoietic colony formation in vitro. Scand. J. Haematol. 37, 79-86.
142. Kremer, J. P., Reisbach, G., Nerl, C., and Dormer, P. (1992). B-cell chronic lymphocyte leukaemia cells express and release transforming growth factor-B. Br. J. Haematol. 80, 480-487.
143. Laerum, O. D., and Maurer, R. (1973). Proliferation kinetics of myelopoietic cells and macrophages in diffusion chambers after treatment with granulocyte extracts (chalone). Virchows Arch. 14, 293-305.
144. Laerum, O. D., and Paukovits, W. R. (1984). Inhibitory effects of a synthetic pentapeptide on haemopoietic stem cells in vitro and in vivo. Exp. Hematol. (Copenhagen) 12, 7-17.
145. Laerum, O. D., Paukovits, W. R., and Sletvold, O. (1986). Hemoregulatory peptide: Biological aspects. In "Biological Regulation of Cell Proliferation" (R. Baserga, P. Foa, D. Metcalf, and E. E. Polli, (eds.), pp. 121-129. Raven Press, New York.
146. Laerum, O. D., Sletvold, O., and Paukovits, W. R. (1987). A synthetic haemoregulatory peptide (HP5b) inhibits human myelopoietic colony (CFU-GM) formation but not leucocyte phagocytosis in vitro. Eur. J. Haematol. 39, 259-266.
147. Laerum, O. D., Sletvold, O., Bjerknes, R., Eriksen, J. A., Johanen, J. H., Schanche, J.-S., Tveteras, T., and Paukovits, W. R. (1988). The dimer of hemoregulatory peptide (HP5b) stimulates human and mouse myelopoiesis in vitro. Exp. Hematol. (Copenhagen) 16, 274-280.
148. Laerum, O. D., Aakvaag, A., Froscad, S., Kalland, T., Langen, P., and Maurer, H. R. (1990a). Selectivity of hemoregulatory peptide (HP5b) action in culture. Int. J. Cell. Cloning 8, 431-444.
149. Laerum, O. D., Frostad, S., Ton, H. I., and Kamp, D. (1990b). The sequence of the hemoregulatory peptide is present in Gia proteins. FEBS Lett. 209, 11-14.
150. Lagneaux, L., Delforge, A., Dorval, C, Brone, D., and Strychman, S. P. (1993). Excessive production of transforming growth factor-β by bone marrow stromal cells in B-cell chronic lymphocyte inhibits growth of heamotopoietic precursors and interleukin-6 production. Blood 82, 2379-2385.
151. Lahio, J. A., De Caprio, D., Ludlow, J. W., Livingstone, D. M., and Massague, J. (1990). Growth inhibition by TGFβ to suppression of retinoblastoma protein phosphorylation. Cell (Cambridge, Mass.) 62, 175-185.
152. Laiho, M., Ronnstrand, L., Heino, J., De Caprio, J. A., Ludlow, J. W., Livingstone, D. M., and Massagué, J. (1991). Control of junB and extracellular matrix protein expression by transforming growth factor-beta I is independent of simian virus 40T antigen sensitive growth-inhibitory events. Mol. Biol. Cell 11, 972-978.
153. Lajtha, L. G. (1963). On the concept of the cell cycle. J. Cell. Comp. Physiol. 62, Suppl. 1, 143.
154. Lane, D. P., and Benchimol, S. (1990). P53. Oncogene or antioncogene. Genes Dev. 4, 1-8.
155. Lardon, F., Snoeck, H.-W., Nijs, G., Lenjou, M., Peetermans, M. E., Rodrigus, I., Berneman, Z. N., and van Bockstaele, D. R. (1994). Transforming growth factor β regulates the cell cycle status of interleukin-3 (IL-3) plus IL-1, stem cell factor of IL-6 stimulated CD34+ human haematopoietic progenitor cells through different cell kinetic mechanisms depending on the applied stimulus. Exp. Hematol. (Copenhagen) 22, 903-909.
156. Laterveer, L., Lindley, I. J. D., Hamilton, M. S., Willsemze, R., and Fibbe, W. E. (1995). Interleukin-8 induces rapid mobilization of haematopoietic stem cells radioprotective capacity and long term myelolymphoid populating ability. Blood 85, 2269-2275.
157. Lauret, E., Dumenil, D., Miyanomae, T., and Sainteny, F. (1989a). Further studies on the biological activities of the CFU-S inhibitory tetrapeptide AcSDKP. II. Unresponsiveness of isolated adult rat hepatocytes, 3T3, FDC-P2 and K562 cell lines to AcSDKP. Possible involvement of intermediary cell(s) in the mechanism of AcSDKP action. Exp. Hematol. (Copenhagen) 17, 1081-1085.
158. Lauret, E., Miyonomae, T., Troalen, F., Sotty, D., and Frindel, E. (1989b). Abrogation of the biological activity of the inhibitor AcSDKP by a polyclonal antiserum. Leukaemia 3, 315-317.
159. Lauria, F., Bagnor, G. P., Catari, L., Gaggiolo, L., Guarini, A., Raspadori, D., Foa, R., Bellone, G., Buzzi, M., Gugliota, L., Zauli, G., Giovannini, M., Zuizani, P. L., and Tura, S. (1989). The inhibitory effect of serum from hairy cell leukaemia patients on normal progenitor cells may disappear following prolonged treatment with alpha interferon. Br. J. Haematol. 72, 297-325.
160. Lawrence, D., Pircher, R., and Jalkanen, P. (1985). Conversion of a high molecular weight latent beta-TGF from chicken embryo fibroblasts into a low molecular weight active beta TGF under acidic conditions. Biochem. Biophys. Res. Commun. 133, 1026-1043.
161. high cells. Blood 78, 24(abstr.).
162. Lenfant, M., Wdzieczak-Bakala, J., Guittet, E., Prome, J. C, Sotty, D., and Frindel, E. (1989). Inhibitor of haematopoietic pluripotent stem cell proliferation: purification and determination of its structure. Proc. Natl. Acad. Sci. U.S.A. 36, 779-782.
163. Lenfant, M., Itoh, K., Sakoda, H., Sotty, D., Sasaki, A., Wdzieczak-Bakala, J., and Mori, K. (1990). Enhancement of the adherence of haematopoietic stem cells to mouse bone marrowderived stromal cell line M-S-1-Tby a tetrapeptide Acetyl-N-Ser-Asp-lys-Pro. Exp. Hematol. (Copenhagen) 18, 112-115.
164. Lindeman, A., Ludwig, W. D., Mertelsmann, R., Oster, W., and Hermann, F. (1989). High level secretion of TNF alpha contributes to heamopoietic failure in hairy cell leukaemia. Blood 73, 880-884.
165. Liozon, E., Pradelles, P., Venot, J., Rigaud, M., Cransoc, M., Bordessoule, D., and Frindel, E. (1993). Serum levels of a negative regulator of cell proliferation (AcSDKP) are increased in certain homeopathies. Leukaemia 7, 808-812.
166. Lord, B. I. (1975). Modification of granulocytopoietic cell proliferation by granulocyte extracts. Boll. Ist. Sieroter. Milan. 54, 187-194.
167. 0 to the cell cycle of haemopoietic spleen colony forming cells. Cell Tissue Kinet. 14, 425-431.
168. Lord, B. I. (1988). The recovery of bone marrow following cytotoxic treatment. Med. Sci. Res. 16, 37-38.
169. Lord, B. I. (1995). MIPla increases the self renewal capacity of the haemapoietic spleen colony forming cells following hydroxyurea treatment in vivo. Growth Factors 12, 145-149.
170. Lord, B. I., and Hendry, J. H. (1972). The distribution of haemopoietic colony forming units in the mouse femur and its modification by X-rays. Br. J. Radial 45, 110-115.
171. Lord, B. I., and Schofield, R. (1980). Some observations on the kinetics of haemopoietic stem cells and their relationship to the spatial cellular organisation of the tissue. Lea. Notes Biomath. 38, 9-18.
172. Lord, B. I., and Woolford, L. B. (1993). Proliferation of spleen colony forming units (CFU-S8, CFU-Sn) and cells with marrow repopulating ability. Stem Cells 11, 212-217.
173. Lord, B. I., and Wright, E. G. (1980). Sources of hemopoieticstem cell proliferation: stimulators and inhibitors. Blood Cells 6, 581-593.
174. Lord, B. I., Lajtha, L. G., and Gidali, J. (1974a). Measurement of the kinetic status of bone marrow precursor cells. Three cautionary tales. Cell Tissue Kinet. 7, 507-515.
175. Lord, B. I., Cercek, L., Cercek, B., Shah, G. P., Dexter, T. M., and Lajtha, L. G. (1974b). Inhibitors of haemopoietic cell proliferation? Specificity of action within the haemopoietic system. Br. J. Cancer 29, 168-175.
176. Lord, B. L, Mon, K. J., Wright, E. G., and Lajtha, L. G. (1976). An inhibitor of stem cell proliferation in normal bone marrow. Br. J. Haematol. 34, 441-445.
177. Lord, B. L, Mori, K. J., and Wright, E. G. (1977a). A stimulator of stem cell proliferation in regenerating bone marrow. Biomed. Exp. 27, 223-226.
178. Lord, B. L, Testa, N. G., Wright, E. G., and Bannerjee, R. K. (1977b). Lack of effect of a granulocyte proliferation inhibitor on their committed precursor cells. Biomedicine 26, 163-165.
179. Lord, B. L, Wright, E. G., and Lajtha, L. G. (1979). Actions of the haemopoietic stem cell proliferation inhibitor. Biochem. Pharmacol. 28, 1843-1848.
180. Lord, B. I., Liu, F.-L., Podja, Z., and Spooncer, E. (1987). Inhibitor of haemopoietic CFU- S proliferation: Assays, production sources and regulatory mechanisms. Colloq.-Inst. Natl. Sante Rech. Med. 162, 227-240.
181. Lord, B. I., Dexter, T. M., Clements, J. M., Hunter, M. G., and Gearing, A. J. H. (1992). Macrophage inflammatory protein protects multipotent haeamopoietic cells from the cytotoxic effects of hydroxyurea in vivo. Blood 79, 2605-2609.
182. Lord, B. I., Heyworth, C. M., and Woolford, L. B. (1993). Macrophage inflammatory protein: Its characteristics, biological properties and role in the regulation of haemopoiesis. Int. J. Haematol. 57, 197-206.
183. Lord, B. I., Woolford, L. B., Wood, L. M., Czaplewski, L. G., McCourt, M., Hunter, M. G., and Edwards, R. M. (1995). Mobilization of early haematopoietic progenitor cells with BB10010: A genetically engineered variant of human macrophage inflammatory proteinla. Blood 85, 3412-3415.
184. Lord, B. I., Marshall, E., and Woolford, L. (1996). Protection, in vivo, by BB10010 (MIP1α) against repeated treatments with non-cycle active cytotoxic agents: Sub-lethal irradiated. Submitted for publication.
185. Lorimore, S. A., Eckmann, L., Pragnell, I. B., and Wright, E. G. (1990). Synergistic interactions allow colony formation in vitro by murine haemopoietic stem cells. Leuk. Res. 14, 481-489.
186. +++ stem/progenitor cells from human bone marrow and umbilical cord blood plated with and without serum. Exp. Hematol. (Copenhagen) 21, 1442-1446.
187. Ludlow, J. W., Shon, J., Pipas, J. M., Livingstone, D. M., and De Caprio, J. A. (1990). The retinoblastoma susceptibility gene product undergoes cell-cyle-dependent dephosphorylation and bind to and release from SV40 large T. Cell (Cambridge, Mass.) 60, 387-396.
188. Lyons, R. M., Keski-Oja, J., and Moses, H. L. (1988). Proteolytic activation of latent transforming growth factor-β from fibroblast-conditioned medium. J. Cell Biol. 106, 1659-1665.
189. Maciejewski, J. P., Liu, J. M., Green, S. W., Walsh, C. E., Plumb, M., Pragnell, I. B., and Young, N. S. (1992). Expression of stem cell inhibitor (SCI) gene in patients with bone marrow failure. Exp. Hematol. (Copenhagen) 20, 1112-1117.
190. Mantel, C., Kim, Y. J., Cooper, S., Kwan, B., and Broxmeyer, H. E. (1993). Polymerization of murine macrophage inflammatory protein-la inactivates its myelosuppressive effects in vivo. Proc. Natl. Acad. Sci. U.S.A. 90, 2232-2236.
191. Massagué, J. (1990). The transforming growth factor beta family, Anna. Rev. Cell Biol. 6, 597-641.
192. Massagué, J. (1992). Receptors for the TGF-beta family. Cell (Cambridge, Mass.) 69, 1067-1070.
193. Massagué, J., and Like, B. (1985). Cellular receptors for type beta transforming growth factor. J. Biol. Chem. 260, 2636-2645.
194. Matthews, L. S., and Vale, W. W. (1991). Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell (Cambridge, Mass.) 65, 973-982.
195. 3H] thymidine techniques to measure cell proliferation. Cell Tissue Kinet. 14, 111-120.
196. Maurer, H. R., Henry, R., and Maschler, R. (1978). Chalone inhibition of granulocyte colony growth in agar: Kinetic quantitiation by capillary tube scanning. Cell Tissue Kinet. 11, 129-138.
197. McColl, S. R., Hachicha, M., Levasseur, S., Neote, K., and Schall, T. J. (1993). Uncoupling of early signal transuction events from effector function in human peripheral blood neutrophils in response to recombinant macrophage inflammatory protein-la and -1β. J. Immunol. 150, 4550-4560.
198. McNiece, I. K., Stewart, F. M., Deacon, D. M., Temeles, D. S., Zsebo, K. M., Clark, S. C., and Quesenberry, P. J. (1989). Detection of a human CFC with high proliferative potential. Blood 74, 609-612.
199. Metcalf, D. (1990). The colony stimulating factors-discovery, development and clinical application. Cancer (Philadelphia) 65, 2185-2195.
200. Migdalska, A., Molineux, G., Demunyck, H., Evans, G. S., Ruscetti, F., and Dexter, T. M. (1991). Growth inhibitory effects of transforming growth factor B1 in vivo. Growth Factors 4, 239-245.
201. Minano, P. J., Vizcaino, M., and Myers, R. D. (1991). Hypothalamic indomethacin fails to block fever induced in rats by central macrophage inflammatory protein-1 (MIP-1). Pharinacol, Biochem. Behav. 39, 535-549.
202. Molineux, G., Migdalska, A., Haley, J., Evans, G. S., and Dexter, T. M. (1994). Total marrow failure induced by pegylated stem cell factor administered before 5-fluorouracil. Blood 83, 3491-3499.
203. Monpezat, J. P., and Frindel, E. (1989). Further studies on the biological activities of the CFU-S inhibitory tetrapeptide AcSDKP. I. The precise point of the cell cycle sensitive to AcSDKP. Studies on the effect of AcSDKP on GM-CFC and on possible involvement of T-lymphocytes in AcSDKP response. Exp. Hematol. (Copenhagen) 17, 1077-1080.
204. Moreb, J., Zucalie, J. R., and Reuth, S. (1990). The effects of tumour necrosis factor-α on early human haematopoietic progenitor cells treated with 4-hydroxyperoxycycIophosphamide. Blood 76, 681-689.
205. Moses, H. L., Tucker, R. F., Leof, E. B., Coffey, R. J., Jr., Halper, J., and Shipley, G. D. (1985). Type transforming growth factor is a growth stimulator and growth inhibitor. Cancer Cells 3, 65-75.
206. Munker, R., Gasson, J., Ogawa, M., and Koeffier, H. P. (1986). Recombinant human TNF induces production of granulocyte-monocyte colony stimulating factor. Nature (London) 323, 79-82.
207. Murphy, M., Perussia, B., and Trinchieri, G. (1988). Effects of recombinant tumour necrosis factor, lymphotoxin and immune interferon on proliferation and differentiation of enriched haematophoietic precursor cells. Exp. Hematol. (Copenhagen) 16, 131-138.
208. Neote, K., DiGregorio, D., Mak, J. Y., Horuk, R., and Schall, T. J. (1993). Molecular cloning, functional expression and signalling characteristics of a c-c chemokine receptor. Cell (Cambridge, Mass.) 72, 415-425.
209. Obaru, K., Fukuda, M., Maeda, S., and Shimada, K. (1986). cDNA clone used to study mRNA inducible in human tonsillar lymphocytes by a tumour promotor. J. Biochem. (Tokyo) 99, 885-894.
210. O'Connor, M. D., and Wakefield, L. M. (1987). Latent transforming growth factor β in serum. A specific complex with a a2-macroglobulin. J. Biol. Chem. 262, 14090-14099.
211. Oh, K.-O., Zhou, Z., Kim, K.-K., Samanta, H., Fráser, M., Kim, Y.-J., Broxmeyer, H. E., and Kwon, W. B. S. (1991). Identification of cell surface receptors for murine macrophage inflammatory protein -la. J. Immunol. 147, 2978-2983.
212. Ohta, M., Greenberger, H. S., Ackesaria, P., Bassol, S. A., and Massague, J. (1987). Two forms of transforming growth factor beta distinguished by multipotential progenitor cells. Nature (London) 239, 539-541.
213. Olsson, I., and Olofsson, T. (1980). Suppression of normal granulopoiesis in vitro by a leukaemia-associated inhibitor (LA1) of acute and chronic leukaemia. Blood 55, 975-982.
214. Oppenheim, J. J., Zacharial, C. O. C, Mukaida, N., and Matoushima, R. (1991). Properties of the novel proinflammatory supergene "intercrine" cytokine family. Anna. Rev. Immunol. 9, 617-648.
215. Oster, W., Lindermann, A., Hor, S., and Herrman, F. (1987). Tumour necrosis factor (TNF)-α but not TNF-β induces secretion of colony stimulating factor for macrophages (CSF-1) by human monocytes. Blood 70, 1700-1703.
216. Otsuka, T., Eaves, C. J., Humphries, R. K., Hogge, D. E., and Eaves, A. C. (1991). Lack of evidence for abnormal autocrine or paracrine mechanisms underlying the uncontrolled proliferation of primitive chronic myeloid leukaemia cells. Leukaemia 5, 861-868.
217. Oilman, O., and Pelus, L. (1988). Differential proliferative effects of transforming growth factor β on human haematopoietic progenitor cells. J. Immunol. 140, 2661-2667.
218. Pardee, A. B. (1989). G, events and regulation of cell proliferation. Science 246, 603-608.
219. Parkinson, E. P., Graham, G. J., Daubersies, P., Burns, J. E., Henflet, C., Plumb, M., Schuler, G., and Pragnell, I. B. (1993). Haemopoietic stem cell inhibition (SCI/MIPla) also inhibits clonogenic epidermal keratinocyte proliferation. J. Invest. Dermatol. 101, 113-117.
220. Paukovits, W. R. (1971). Control of granulocyte production: Separation and chemical identification of a specific inhibitor. Cell Tissue Kinet. 4, 539-547.
221. Paukovits, W. R., and Laerum, O. D. (1982). Isolation and synthesis of a haemoregulatory peptide. Z. Naturforsch. 37, 1297-1300.
222. Paukovits, W. R., Guigon, M., Binder, K. A., Hergyl, A., Laerum, O. D., and Schulte-Hermann, R. (1990). Prevention of haematotoxic side effects of cytostatic drugs in mice by a synthetic hemoregulatory peptide. Cancer Res. 50, 328-332.
223. Paukovits, W. R., Moser, M.-H., Binder, K. A., and Paukovits, J. B. (1991a). Protection from arabinofuranosylcytosine and n-mustard-induced myelotoxicity using hemoregulatory peptide pGlu-Glu-Asp-Cys-Lys monomer and dimer. Blood 77, 1313-1319.
224. Paukovits, W. R., Moser, M. H., Rutter, R., and Paukovits, J. B. (1991b). Inhibition of hemopoietic stem cell proliferation by hemoregulatory peptide PEEDCK provides protection against short term neutropenia and long term damage. Ann. N.Y.Acad. Sci. 628, 92-104.
225. Paukovits, W. R., Moser, M. H., and Paukovits, J. B. (1993). Pre-CFU-S quiescence and stem cell exhaustion afer cytostatic drug treatment. Protective effects of the inhibitory peptide pGlu-Glu-Asp-Cys-Lys (pEEDCK). Blood 81, 1755-1761.
226. Pelus, L. M., King, A. G., Broxmeyer, H. E., Demarsh, P. L., Petteway, S. R., and Bhatnager, P. K. (1994). In vivo modulation of hematopoiesis by a novel hematoregulatory peptide. Exp. Hematol. (Copenhagen) 22, 239-247.
227. Pietenpol, J. A., Stein, R. W., Moran, E., Yaciuk, P., Schelgel, R., Lyons, R. M., Pittelkow, M. R., Munger, K., Howley, P. M., and Moses, H. L. (1990). TGF-B1 inhibition of c-myc transcription and growth in keratinocytes in abrogated by viral transforming proteins with pRB binding domains. Cell (Cambridge, Mass.) 61, 777-785.
228. Pluthero, F. G., and Axelrad, A. A. (1991). Superoxide dismutase as an inhibitor of erythroid progenitor cell cycling. Ann. N.Y. Acad. Sci. 628, 222-232.
229. Pluthero, F. G., Shreeve, M., Eskinazi, D., Van der Gaag, H., Huang, K. S., Hulmes, J. D., Blum, M., and Axelrad, A. A. (1990). Purification of an inhibitor of erythroid progenitor cell cycling and antagonist as cytosolic Superoxide dismutase. J. Cell Biol. Ill, 1217-1223.
230. Polyak, K., Kalo, J.-Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., and Koff, A. (1994). P27kipl, a cyclin-Cdk inhibitor, links transforming growth factor-beta contact inhibition to cell cycle arrest. Genes Dev. 8, 9-22.
231. Potten, C. S., and Hendry, J. H. (1983). Stem cells in murine small intestine and epidermis. In "Stem Cells. Their Identification and Characterisation" (C. Potten, ed.), pp. 155-269 Churchill-Livingstone, Edinburgh.
232. Pradelles, P., Frobert, Y., Creminon, C, Ivonine, H., and Frindel, E. (1991). Distribution of a negative regulator of haematopoietic stem cell proliferation (AcSDKP) and thymosin β4 in mouse tissues. FEES Lett. 289, 171-175.
233. Quesada, J. R., Gutterman, J. U., and Hersh, E. M. (1986a). Treatment of hairy cell leukaemia with alpha interferon. Cancer (Philadelphia) 57, 1678-1680.
234. Quesada, J. R., Alexanian, R., Hawkins, M., Barlogie, B., Borden, E., Itri, L., and Gutterman, U. (1986b). Treatment of multiple myeloma with recombinant a-interferon. Blood 67, 275-278.
235. Quesenberry, P. J., and Stanley, K. (1990). A statistical analysis of murine stem cell suicide techniques. Blood 56, 1000-1004.
236. Quesniaux, V. F. J., Graham, G. J., Pragnell, I. B., Donaldson, D., Wolpe, S. D., iscove, N. N., and Fagg, B. (1993). Use of 5-fiuorouracil to analyze the effect of macrophage inflammatory protein-la on longterm reconstituting stem cells in vivo. Blood 6, 1497-1504.
237. Raefsky, E. L., Platanias, L. C., Zoumbos, N. C., and Young, N. S. (1985). Studies on interferon as a regulator of haematopoietic cell proliferation. J. Immunol. 135, 2507-2512.
238. Ramirez, L. H., Bindoula, G., Grillon, C, Ardouin, P., Munck, J. N., and Carde, P. (1994). Haematopoietic protective effects of seraspenide (AcSDKP) against cytotoxic effects of Adriamycin in mice. European Congress for Clinical Oncology p. 105 (abstr.).
239. Reiger, K. J., Saez-Servent, N., Papet, M. P., Wdzieczak-Bakala, J., Morgat, J. L., Thierry, J., Voelter, W., and Lenfant, M. (1993). Involvement of human plasma anliotensin I-converting enzyme in the degradation of the haemoregulatory peptide N-acetyl-seryl-Aspartyl-lysyl-proline. Biochem. J. 296 (pt 2), 373-378.
240. Reiss, M., Vellucci, V. F., and Zhou, Z.-I. (1993). Mutant p53 tumour suppressor gene causes resistance to transforming growth factor-beta 1 in murine keratinocytes. Cancer Res. 53, 899-904.
241. Rich, I. N., Sawatzki, G. (1987). The role of lactoferrin in regulating colony stimulating factor production. Colloq.-Inst. Natl Sante Rech. Med. 162, 63-66.
242. Robbins, E., and Scharff, M. D., The absence of a detectable GI phase in a cultured strain of Chinese hamster lung cell. J. Cell Biol. 34, 684-697.
243. Roberts, A. B., Anzano, M. A., Myers, C. A., Wideman, J., Blacher, R. etal. (1983). Purification and properties of a type transforming growth factor from bovine kidney. Biochemistry 22, 5692-5698.
244. Roberts, A. B., Anzano, M. A., Wakefield, L. M., Röche, N. S., Stern, D. F., and Sporn, M. B. (1985). Type-/3 transforming growth factor: A bidirectional regulator of cellular growth. Proc. Nail. Acad. Sci. U.S.A. 82, 119-123.
245. Robinson, S., Lenfant, M., Wdzieczak-Bakala, J., Melville, J., and Richer, A. (1992). The mechanism of action of the tetrapeptide AcSDKP in the control of haematopoietic stem cell proliferation. Cell. Proliferation 25, 623-632.
246. Rot, A., Krieger, M., Brunner, T., Bischoff, S. C., Schall, T. J., and Dahinden, C. A. (1992). RANTES and macrophage inflammatory protein-la induce the migration and activation of normal human eosinophil granulocytes. J. Exp. Med. 176, 1489-1495.
247. Ruscetti, F. W., Dubois, C, Folk, L. A., Jacobsen, S. E., Sing, G. K., Longo, D. L., Wiltrout, R. H., and Keller, J. R. (1991). In vivo and in vitro effects of TGF/3 on normal and neoplastic haemopoiesis. Ciba Found. Symp. 1570, 212-231.
248. Rytomaa, T., and Kiviniemi, K. (1968a). Control of granulocyte production. I. Chalone and antichalone, two specific humoral regulators. Cell Tissue Kinet. 1, 329-340.
249. Rytomaa, T., and Kiviniemi, K. (1968b). Control of cell production in rat chloroleukaemia by means of the graulocyte chalone. Nature (London) 200, 136-137.
250. Sagar, R. (1989). Tumour suppression genes: The puzzle and the promise. Science 246, 1406-1412.
251. Sala, G., Woorwood, M., and Jacobs, A. (1986). The effect of isoferritins on granulopoiesis. Blood 67, 436-443.
252. Sancar, A., and Sancar, G. B. (1988). DNA repair enzymes. Annu. Rev. Biochem. 57, 29-67.
253. Sato, N., Sawadi, K. I., Takahashi, T. A., Magi, Y., Asano, S., Koike, T., and Sekiguchi, S. (1994). A time course study for optimal harvest of peripheral blood progenitor cells by granulocyte colony-stimulating factor in healthy volunteers. Exp. Hematol. (Copenhagen) 22, 973-978.
254. Schall, T. J., Bacon, K., Camp, R. D., Kaspari, J. W., and Goeddel, D. V. (1993). Human macrophage inflammatory protein-lot and MIP-1/3 chemokines attract distinct populations of lymphocytes. J. Exp. Med. 177, 1821-1826.
255. Schneider, J. G., and Moore, M. A. S. (1991). TGF/3 but not macrophage inflammatory protein1α (MIP1α) abrogates 11-1 and ckit ligand (KL) induced proliferation of murine high proliferative potential (HPP) colonies. Blood 78, 259. (abstr.).
256. Schofield, R. (1978). The relationship between the spleen colony forming cells and the haemopoietic stem cell. A hypothesis. Blood Cells 4, 7-25.
257. Sherry, B., Tekamp-Olson, P., Gallegos, C, Bauer, D., Davatelis, G., Masiarz, F., Coit, D., and Cerami, A. (1988). Resolution of the two components of macrophage inflammatory protein 1, and cloning and characterization of one of these components, macrophage inflammatory protein-1β. J. Exp. Med. 168, 2251-2259.
258. Silberberg, D. H. (1994). Specific treatment of multiple sclerosis. Clin. Neurosci. 2, 271-274.
259. Simmons, P. J., and Lord, B. I. (1985). Enrichment of CFU-S proliferation inhibitor-producing cells based on their identification by the monoclonal antobody F4/80. J. Cell. Sci. 78, 117-131.
260. Sing, G. K., Keller, J. R., Ellingsworth, L. R., and Ruscetti, F. W. (1988). Transforming growth factor β selectively inhibits normal and leukaemic human bone marrow cell growth in vitro. Blood 72, 1504-1511.
261. Skraastad, O., Forsli, T., Reichelt, K. L., and Cromarty, A. (1987). Purification of an endogenous inhibitor of cell proliferation in colon. 15th Eur. Meet. Eur. Study Group Cell Proliferation, Sundrolden, Norway, 1987, Abstr., p. 17.
262. Sonis, S. T., Linquist, L., Van Vugt, A., Stewart, A. A., Stam, K., Qu, G.-Y., Iwata, K. K., and Haley, J. D. (1994). Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor-beta 3. Cancer Res. 54, 1135-1138.
263. Sozzani, S., Molino, M., Locati, M., Luini, W., Cerletti, C, Vecchi, A., and Mantovani, A. (1993). Receptor-activated calcium influx in human monocytes exposed to monocyte chemotactic protein-1 and related cytokines. J. Immunol. 150, 1544-1553.
264. Sporn, M. B., Roberts, A. B., Shull, J. H., Smith, J. M., Ward, M., and Sodek, J. (1983). Polypeptide transforming growth factors isolated from bovine sources and used for wound healing in vivo. Science 219, 1329-1330.
265. Sprangrude, G., Heimfeld, S., and Weissman, I. L., (1988). Purification and characterization of mouse haemopoietic stem cells. Science 241, 58-62.
266. Steinberg, H. N. (1987) Suppression of normal heamopoiesis in leukaemia in vivo and in vitro studies. Colloq.-Inst. Natl. Santc Rech. Med. 162, 163-175.
267. Stryckmans, P., Vandenplas, B., Dorval, C., Vandenbussche, P., Massy, M., Bernier, M., and Content, J. (1988). Decreased production of IL-6 by peripheral blood mononuclear cells of patients with chronic lymphocyte leukaemia and related disorders. Nouv. Rev. Fr. Hematol. 30, 321-323.
268. Sutherland, H. J., Lansdorp, P. M., Henkelman, D. H., Eaves, A. C, and Eaves, C. J. (1990). Functional characterization of individual human haematopoietic stem cells cultured at limiting dilution on supportive marrow stromal cells. Proc. Natl. Acad. Sci. U.S.A. 87, 3584-3588.
269. Talpaz, M., Kantarjian, H. M., McCredie, K. B., Keating, M. J., Trujillo, J., and Gutterman, J. (1987). Clinical investigation of human interferon alpha in chronic myelogenous leukaemia. Blood 69, 1280-1288.
270. Taylor-Papadimitriou, J. (1980). Effects of interferon on cell growth and function. In "Interferon 2" (I. Gresser, ed.), pp. 13-46. Academic Press, New York.
271. Tejero, C., Testa, N. G., and Lord, B. I. (1984). The cellular specificity of haemopoietic stem cell proliferation regulators. Br. J. Cancer 50, 335-341.
272. Testa, N. G., Hendry, J. H., and Molineux, G. (1990). Long term bone marrow damage in experimental systems and in patients after radiation or chemotherapy. Anticancer. Res. S, 101-110.
273. Till, J. E., and McCulloch, E. A. (1981). A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 14, 213-216.
274. Toksoz, D., Dexter, T. M., and Lord, B. I. (1980). The regulation of haemopoiesis in long term marrow cultures. II. Stimulation and inhibition of stem cell proliferation. Blood 55, 931-936.
275. Tominaga, S., and Lengyel, P. (1985). interferon alters the patterns of proteins secreted from qiuescent and platelet-derived growth factor-treated B ALB/C-3T3 cells. J. Biol. Chem. 260, 1975-1978.
276. Tsujimoto, M., and Vilcek, J. (1986). Tumour necrosis factor receptors in HeLa cells and their regulation by interferon-y. J. Biol. Chem. 261, 5284-5388.
277. Tsyrlova, I. G., and Lord, B. I. (1989). Inhibitor of CPUS proliferation preserves normal haemopoiesis from cytotoxic drug in long term bone marrow-L1210 leukaemia model. Leuk. Res. 13, Suppl. 1, 14.
278. Van Riper, G., Nicholson, D. W., Scheid, M. P., Fischer, P. A., Springer, M. S., and Rosen, H. (1994). Induction, characterisation and functional coupling of the high affinity chemokine receptor for RANTES and macrophage inflammatory protein-1α upon differentiation of an eosinophilic HL-60 cell line. J. Immunol. 152, 4055-4061.
279. Veiby, O. P., Olsen, W. M., LoCastro, S., and Bhatnager, P. (1994). Inhibition of enriched stem cells in vivo and in vitro by the hemoregulatory peptide SK 108636. Exp. Itematol. (Copenhagen) 22, 791(abstr.).
280. Verfaule, C. M. (1994). Regulation of human haematopoiesis by the bone marrow environment. Exp. Hematol. (Copenhagen) 22, 714(abstr.).
281. Verfaule, C. M., Catanzarro, P. M., and Li, W. (1994). Macrophage inflammatory protein 1α, Interleukin 3 and diffusable marrow stromal factors maintain human haematopoietic stem cells for at least eight weeks in vitro. J. Exp. Med. 179, 643-649.
282. Voaden, M., and Leeson, S. (1969). A chalone in the mammalian lens. Exp. Eye Res. 8(2), 231-232.
283. Wang, J. M., Sherry, B., Fivash, M. J., Kelvin, D. J., and Oppenheim, J. J. (1993). Human recombinant macrophage inflammatory protein-1α and -beta and monocyte chemotactic and activating factor utilise common and unique receptors on human monocytes. J. Immunol. 150, 3022-3029.
284. Wdzieczak-Bakala, J., Fache, M. P., Lenfant, M., Frindel, E., and Sainteny, F., (1990). AcSDKP, an inhibitor of CFU-S proliferation is synthesised in mice under steady state conditions and secreted by bone marrow in long term culture. Leukaemia 4, 235-237.
285. Weiss, P., and Kavanau, J. L. (1957). A model of growth and control in mathematical terms. J. Gen. Physiol. 41, 1-47.
286. Widmer, U., Yang, Z., Van Deventer, S., Manogue, K. R., Sherry, B., and Cerami, A. (1991). Genomic structure of murine macrophage inflammatory protein-la and conservation of potential regulatory sequences with a human homologue, LD78.7. ImmunoL 146, 4031-4040.
287. Wilcox, J. N., and Derynck, R. (1988). Developmental expression of transforming growth factors alpha and beta in mouse fetus. Mol. Cell. Biol. S, and 3415-3422.
288. Winton, E. F., Kinkade, J. M. Jr., Vogler, W. R., Parker, M. B., and Barnes, C. B. (1981). In vitro studies of lactoferrin and murine granulopoiesis. Blood 57, 574-578.
289. Wisniewski, D., Strife, A., Atzpodien, J., and Clarkson, B. D. (1987). Effects of recombinant human tumour necrosis factor on highly enriched haematopoietic progenitor cell population from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukaemia. Cancer Res. 47, 4788-4794.
290. Wolpe, S. D., and Cerami, A. (1989). Macrophage Inflammatory proteins 1 and 2: Members of a novel superfamily of cytokines. FASEB J. 3, 2565-2573.
291. Wolpe, S. D., Davatelis, S. G., Sherry, B., Beutler, B., Hesse, D. G., Nguyen, H. T., Moldawer, L. L., Nathan, L. F., Lowry, S. F., and Cerami, A. (1988). Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J. Exp. Med. 167, 570-581.
292. Wright, E. G., Garland, J. M., and Lord, B. I. (1980). Specific inhibition of haemopoietic stem cell proliferation: Characteristics of the inhibitor producing cells. Leuk. Res. 4, 537-545.
293. Wright, E. G., Ali, A. M., Riches, A. C, and Lord, B. I. (1982). Stimulation of haemopoietic stem cell proliferation: Characteristics of the stimulator producing cells. Leuk. Res. 6, 531-539.
294. Wright, E. G., Lorimore, S. A., and Lord, B. I. (1985). Effect of haemopoietic stem cell proliferation regulators on early and late spleen colony-forming cells. Cell Tissue Kinet. 18, 193-199.
295. Yamamura, Y., Hattori, T., and Obaru, K. (1989). Synthesis of a novel cytokine and its gene (LD78) expressions in haematopoietic fresh tumour cells and cell lines. J. Clin. Invest. 84, 1707-1712.
296. Zhou, Z., Kim, Y.-J., Pollock, K., Hurtado, J., Lee, J. K., Broxmeyer, H. E., and Kwon, B. S. (1993). Macrophage inflammatory protein la rapidly modulates its receptors and inhibits the anti-CD3 m AB-mediated proliferation of T lymphocytes. J. Immunol. 151, 4333-4341.
297. Zipfel, P. F., Balke, J., Irving, S. G., Kelly, K., and Sienbenlist, U. (1989). Mitogenic activation of human T cells induces two closely related genes which share structural similarities with a new family of secreted factors. J. Immunol. 142, 1582-1590.
298. Zucali, J. R., Broxmeyer, H. E., Levy, D., and Morse, C. (1989). Lactoferrin decreases monocyte induced fibroblast production of myeloid colony stimulating activity by suppressing monocyte release of interleukin 1. Blood. 74, 1531-1536.
299. Zullo, J. N., cochran, B. H., Huang, A. S., and Stiles, C. D. (1985). Platelet-derived growth factor and double stranded ribonucleic acids stimulate expression of the same genes in 3T3 cells. Cell (Cambridge, Mass.) 43, 793-800.